Transcatheter therapies for resistant hypertension: Clinical review

Table 1 Renal artery stenting/angioplasty in resistant hypertension

Ref.	Size	Follow up period	Mean SBP reduction with stenting/ angioplasty	Mean SBP reduction with medical therapy	P value
Cooper et al[3] (Coral trial)	947	43 mo	16.6 ± 21.2	15.6 ± 25.8	0.03
Van Jaarsveld et al[7] (DRASTIC trial)	106	12 mo	19	17	0.51
Plouin et al[5] (EMMA trial)	49	6 mo	12 ± 20	8 ± 16	0.46
Webster et al[6]	135	3-54 mo	34	8	0.018

SBP: Systolic blood pressure.